Skip to main content

Ciaramella Giuseppe's Form 4 filing

Beam Therapeutics Inc. (BEAM) · filed Oct 16, 2024

Accession no.
0000950170-24-115031
Filed
Oct 16, 2024
Trade date
Oct 14, 2024
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.34M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Ciaramella GiuseppeCIK 0001786322Officer (President)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 14, 2024Common StockMOption exerciseAcquired+27,318$0.67+$18,303.06196,934Direct
Oct 14, 2024Common StockMOption exerciseAcquired+12,979$4.22+$54,771.38209,913Direct
Oct 14, 2024Common StockMOption exerciseAcquired+1,457$7.22+$10,519.54211,370Direct
Oct 14, 2024Common StockSSaleDisposed−51,110$26.27−$1,342,659.7160,260Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Oct 14, 2024Comon StockMOption exerciseDisposed−27,318$0.00$00Direct
Oct 14, 2024Comon StockMOption exerciseDisposed−12,979$0.00$00Direct
Oct 14, 2024Comon StockMOption exerciseDisposed−1,457$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)